Infosys Ltd (INFY) Stock Analysis and Metrics

Infosys

NYSE: INFY

$11.12 ▲ +0.45 (+4.22%)

At close: Jul 24, 2026 · 3:59 PM UTC

Financial Ratios

Market Cap44.05 Bn

P/E0.29

P/S0.05

Div. Yield0.05

ROIC (Qtr)0.56

Add ratio to table…

About

Infosys Limited is a leading provider of consulting technology outsourcing and next generation digital services enabling clients worldwide to create and execute strategies for their digital transformation.

The company generates revenue by offering consulting technology implementation application management infrastructure management business process management and digital solutions such as Experience Insight Innovate Accelerate Assure and core services to enterprises across various industries.

The company operates through the following segments: Financial Services Retail Communications Energy Utilities Resources and Services Manufacturing Hi Tech Life Sciences and All Other segments.

• The Financial Services segment provides consulting technology implementation application management infrastructure management and digital solutions to banks insurance companies and other financial institutions.

• The Retail segment serves retail consumer packaged goods and logistics companies with consulting technology implementation application management infrastructure management and digital solutions.

• The Communications segment offers consulting technology implementation application management infrastructure management and digital solutions to communication telecom OEM and media companies.

• The Energy Utilities Resources and Services segment delivers consulting technology implementation application management infrastructure management and digital solutions to energy utilities resources and service providers.

• The Manufacturing segment supports manufacturing firms with consulting technology implementation application management infrastructure management and digital solutions.

• The Hi Tech segment provides consulting technology implementation application management infrastructure management and digital solutions to high technology companies.

• The Life Sciences segment serves life sciences and health care organizations with consulting technology implementation application management infrastructure management and digital solutions.

• The All Other segments include India Japan China Infosys Public Services and other public sector enterprises receiving consulting technology implementation application management infrastructure management and digital solutions.

Infosys Limited holds a leading position among global IT services firms competing with companies such as Tata Consultancy Services Wipro HCL Technologies Accenture and IBM. Its competitive advantages include a large scale global delivery model proprietary intellectual property strong client relationships and a focus on innovation in areas such as artificial intelligence cloud computing and cyber security.

The company serves a diverse range of enterprises including Fortune 500 companies banks insurers retailers manufacturers telecommunications providers energy utilities and health care organizations across North America Europe Asia Pacific and other regions.

Investment Thesis

▲ Bull case

Infosys is positioned to capture significant upside from its enterprise AI initiatives, which management emphasized are scaling across sales, marketing, software development, operations, and customer service functions, despite not yet disclosing direct revenue contributions. The company highlighted strong traction in transforming entire enterprises into AI leaders, with a broad set of projects underway and a growing order book that remains underreported. This internal scaling, coupled with partnerships with major tech firms, suggests a latent revenue stream that could materialize as clients move from pilot to production-scale AI deployments. The reluctance to quantify AI revenue now may reflect a strategic choice to avoid premature disclosure while building a robust pipeline, which could translate into meaningful top-line acceleration in H2 FY26 as enterprise AI adoption accelerates globally. The $1.6 billion NHS mega deal, announced post-quarter but pre-earnings, further validates Infosys’ ability to win large-scale public-sector transformation contracts where AI is embedded as a core component, signaling a repeatable model for similar opportunities in other regulated industries like healthcare and government across Europe and North America.
The company’s Project Maximus initiative is delivering tangible and sustainable margin expansion, having contributed 30 basis points of the 20 basis point sequential sequential margin improvement in Q2 FY26, driven by pricing improvements and operational efficiencies. This initiative, which encompasses pricing, automation, and process enhancements, is not a one-time cost-cutting effort but a structural program that has historically delivered 50 basis points of margin expansion year-over-year despite headwinds like higher variable pay and mega-deal ramp-up costs. Management’s confidence in tightening full-year revenue guidance to 2%-3% (from 1%-3%) reflects increased conviction in demand stability, particularly in resilient verticals like financial services and manufacturing, where pipeline strength remains robust. The continued hiring of 8,000 net employees and onboarding of 12,000 freshers in H1 FY26 — tracking toward a 20,000 annual goal — indicates management’s belief in sustained demand, with freshers being deployed on AI and modernization projects that yield long-term productivity gains. This talent pipeline, combined with nearshore center expansion in regions like Canada, Mexico, and Latin America, reduces reliance on H-1B visas and mitigates geopolitical risk while supporting scalable delivery capacity.
Infosys’ capital allocation strategy, underscored by the INR 18,000 crores buyback at INR 1,800 per share, signals strong confidence in intrinsic value and generates shareholder returns without compromising growth investments. The buyback, aligned with its 85% free cash flow return policy over five years, is being executed despite macro uncertainty, reflecting management’s view that the current valuation does not fully capture the company’s defensive characteristics, recurring revenue base, and structural advantages in cost optimization and AI-driven efficiency. The company’s geographic diversification — particularly strong performance in Europe and growing U.S. nearshore capabilities — provides a buffer against regional slowdowns, while its focus on public sector, healthcare, and AI-enabled legacy modernization opens new avenues for high-margin, long-term contracts. The Versent Group acquisition, though pending regulatory approval, represents a strategic move into digital and AI/cloud capabilities that could enhance Infosys’ ability to compete in high-growth niches, with potential contribution expected post-closure in coming quarters.

Infosys is positioned to capture significant upside from its enterprise AI initiatives, which management emphasized are scaling across sales, marketing, software development, operations, and customer service functions, despite not yet disclosing direct revenue contributions. The company highlighted strong traction in transforming entire enterprises into AI leaders, with a broad set of projects underway and a growing order book that remains underreported. This internal scaling, coupled with partnerships with major tech firms, suggests a latent revenue stream that could materialize as clients move from pilot to production-scale AI deployments. The reluctance to quantify AI revenue now may reflect a strategic choice to avoid premature disclosure while building a robust pipeline, which could translate into meaningful top-line acceleration in H2 FY26 as enterprise AI adoption accelerates globally. The $1.6 billion NHS mega deal, announced post-quarter but pre-earnings, further validates Infosys’ ability to win large-scale public-sector transformation contracts where AI is embedded as a core component, signaling a repeatable model for similar opportunities in other regulated industries like healthcare and government across Europe and North America.
The company’s Project Maximus initiative is delivering tangible and sustainable margin expansion, having contributed 30 basis points of the 20 basis point sequential sequential margin improvement in Q2 FY26, driven by pricing improvements and operational efficiencies. This initiative, which encompasses pricing, automation, and process enhancements, is not a one-time cost-cutting effort but a structural program that has historically delivered 50 basis points of margin expansion year-over-year despite headwinds like higher variable pay and mega-deal ramp-up costs. Management’s confidence in tightening full-year revenue guidance to 2%-3% (from 1%-3%) reflects increased conviction in demand stability, particularly in resilient verticals like financial services and manufacturing, where pipeline strength remains robust. The continued hiring of 8,000 net employees and onboarding of 12,000 freshers in H1 FY26 — tracking toward a 20,000 annual goal — indicates management’s belief in sustained demand, with freshers being deployed on AI and modernization projects that yield long-term productivity gains. This talent pipeline, combined with nearshore center expansion in regions like Canada, Mexico, and Latin America, reduces reliance on H-1B visas and mitigates geopolitical risk while supporting scalable delivery capacity.
Infosys’ capital allocation strategy, underscored by the INR 18,000 crores buyback at INR 1,800 per share, signals strong confidence in intrinsic value and generates shareholder returns without compromising growth investments. The buyback, aligned with its 85% free cash flow return policy over five years, is being executed despite macro uncertainty, reflecting management’s view that the current valuation does not fully capture the company’s defensive characteristics, recurring revenue base, and structural advantages in cost optimization and AI-driven efficiency. The company’s geographic diversification — particularly strong performance in Europe and growing U.S. nearshore capabilities — provides a buffer against regional slowdowns, while its focus on public sector, healthcare, and AI-enabled legacy modernization opens new avenues for high-margin, long-term contracts. The Versent Group acquisition, though pending regulatory approval, represents a strategic move into digital and AI/cloud capabilities that could enhance Infosys’ ability to compete in high-growth niches, with potential contribution expected post-closure in coming quarters.

▼ Bear case

Infosys’ revenue growth remains tepid and heavily reliant on cost optimization and automation deals rather than genuine growth spending, with management acknowledging continued constraints in retail and only “good traction” in manufacturing and financial services — verticals where peers are seeing stronger recovery. The guidance tightening to 2%-3% constant currency growth, while framed as increased confidence, still implies minimal expansion and reflects a lack of conviction in a broad-based demand rebound, especially given the CFO’s explicit statement that the lower end of guidance assumes “worsening of the environment” and the upper end only “stability.” This cautious outlook is underscored by the fact that Q2’s 2.2% sequential growth, if sustained, would only yield flat growth for H2 FY26, leaving the company vulnerable to any further macroeconomic deterioration. The heavy emphasis on large deals ($3.1 billion signed in Q2) masks a potential quality issue, as 67% being new or net new work may reflect clients shifting existing work to new contracts rather than incremental spending, raising concerns about the sustainability of deal velocity without true budget growth.
The company’s margin expansion is increasingly dependent on tactical levers like pricing and subcontractor management rather than structural operational excellence, with Project Maximus contributing 30 basis points of margin gain partly offset by higher subcontracting costs and lower on-site utilization — a troubling sign that efficiency gains are being eroded by rising external dependencies and underutilized workforce. Management’s admission that fresher hiring is not differentiated by skill level (“we don’t really split out how many of them are higher skills”) suggests a risk of talent dilution, where the influx of 12,000 freshers in H1 may not translate into proportional productivity gains, especially if training does not keep pace with AI and cloud skill demands. This is compounded by rising voluntary attrition year-over-year, which, despite a sequential dip, indicates underlying dissatisfaction or competitive pressure in retaining experienced staff — a critical risk as Infosys pushes into complex AI transformations that require deep expertise. The nearshore strategy, while presented as a hedge against H-1B restrictions, remains vaguely quantified, with no disclosure on the percentage of U.S.-based employees in nearshore locations, leaving investors uncertain about its actual scalability and cost-effectiveness.
Infosys’ reluctance to disclose AI revenue contribution, despite peers like HCL Tech quantifying theirs, raises concerns about the commercial maturity and monetization path of its AI offerings, suggesting that much of the current activity may be in early-stage pilots or internal experimentation rather than revenue-generating engagements. The lack of clarity on indemnity and risk-sharing in hyperscaler partnerships — where management admitted liability questions are “not fully clarified from a legal perspective” — exposes the company to potentially significant financial exposure if AI-driven projects fail or underperform, especially given the strategic emphasis on enterprise-wide AI transformations. Furthermore, the DOJ investigation into H-1B practices, though met with “no comments,” represents an unquantified legal and reputational risk that could result in fines, operational restrictions, or forced changes to its global delivery model. The Versent acquisition’s pending regulatory approval and lack of current financial contribution highlight execution risk in M&A, with no timeline for closure and no guarantee that the anticipated digital/AI/cloud capabilities will integrate smoothly or deliver expected synergies, particularly if integration delays erode the expected contribution to growth and margins.

Infosys’ revenue growth remains tepid and heavily reliant on cost optimization and automation deals rather than genuine growth spending, with management acknowledging continued constraints in retail and only “good traction” in manufacturing and financial services — verticals where peers are seeing stronger recovery. The guidance tightening to 2%-3% constant currency growth, while framed as increased confidence, still implies minimal expansion and reflects a lack of conviction in a broad-based demand rebound, especially given the CFO’s explicit statement that the lower end of guidance assumes “worsening of the environment” and the upper end only “stability.” This cautious outlook is underscored by the fact that Q2’s 2.2% sequential growth, if sustained, would only yield flat growth for H2 FY26, leaving the company vulnerable to any further macroeconomic deterioration. The heavy emphasis on large deals ($3.1 billion signed in Q2) masks a potential quality issue, as 67% being new or net new work may reflect clients shifting existing work to new contracts rather than incremental spending, raising concerns about the sustainability of deal velocity without true budget growth.
The company’s margin expansion is increasingly dependent on tactical levers like pricing and subcontractor management rather than structural operational excellence, with Project Maximus contributing 30 basis points of margin gain partly offset by higher subcontracting costs and lower on-site utilization — a troubling sign that efficiency gains are being eroded by rising external dependencies and underutilized workforce. Management’s admission that fresher hiring is not differentiated by skill level (“we don’t really split out how many of them are higher skills”) suggests a risk of talent dilution, where the influx of 12,000 freshers in H1 may not translate into proportional productivity gains, especially if training does not keep pace with AI and cloud skill demands. This is compounded by rising voluntary attrition year-over-year, which, despite a sequential dip, indicates underlying dissatisfaction or competitive pressure in retaining experienced staff — a critical risk as Infosys pushes into complex AI transformations that require deep expertise. The nearshore strategy, while presented as a hedge against H-1B restrictions, remains vaguely quantified, with no disclosure on the percentage of U.S.-based employees in nearshore locations, leaving investors uncertain about its actual scalability and cost-effectiveness.
Infosys’ reluctance to disclose AI revenue contribution, despite peers like HCL Tech quantifying theirs, raises concerns about the commercial maturity and monetization path of its AI offerings, suggesting that much of the current activity may be in early-stage pilots or internal experimentation rather than revenue-generating engagements. The lack of clarity on indemnity and risk-sharing in hyperscaler partnerships — where management admitted liability questions are “not fully clarified from a legal perspective” — exposes the company to potentially significant financial exposure if AI-driven projects fail or underperform, especially given the strategic emphasis on enterprise-wide AI transformations. Furthermore, the DOJ investigation into H-1B practices, though met with “no comments,” represents an unquantified legal and reputational risk that could result in fines, operational restrictions, or forced changes to its global delivery model. The Versent acquisition’s pending regulatory approval and lack of current financial contribution highlight execution risk in M&A, with no timeline for closure and no guarantee that the anticipated digital/AI/cloud capabilities will integrate smoothly or deliver expected synergies, particularly if integration delays erode the expected contribution to growth and margins.

Products and services [axis] Breakdown of Revenue (2026)

Peer Comparison

Companies in the Information Technology Services

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	IBM	International Business Machines Corp	193.88 Bn	8,812.83	2.81	61.99 Bn
2	ACN	Accenture plc	84.94 Bn	10.70	1.16	5.14 Bn
3	GDS	GDS Holdings Ltd	50.55 Bn	126.44	29.45	-
4	INFY	Infosys Ltd	44.05 Bn	0.29	0.05	-
5	GIB	Cgi Inc	41.25 Bn	0.32	3.47	2.65 Bn
6	FIS	Fidelity National Information Services, Inc.	20.63 Bn	134.81	1.80	16.99 Bn
7	CTSH	Cognizant Technology Solutions Corp	20.39 Bn	9.24	0.95	0.57 Bn
8	WIT	Wipro Ltd	18.65 Bn	12.56	1.80	1.88 Bn

Research Tools

Developers

About

Investment Thesis

Geographical areas [axis] Breakdown of Revenue (2026)

Products and services [axis] Breakdown of Revenue (2026)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Geographical areas [axis] Breakdown of Revenue (2026)

Products and services [axis] Breakdown of Revenue (2026)

Peer Comparison

Create an account

Sign In

Reset Password